• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ets-1转录因子在皮肤血管肉瘤中的过表达。

Overexpression of Ets-1 transcription factor in angiosarcoma of the skin.

作者信息

Naito S, Shimizu K, Nakashima M, Nakayama T, Ito T, Ito M, Yamashita S, Sekine I

机构信息

Tissue and Histopathology Section, Nagasaki University School of Medicine, Japan.

出版信息

Pathol Res Pract. 2000;196(2):103-9. doi: 10.1016/S0344-0338(00)80041-2.

DOI:10.1016/S0344-0338(00)80041-2
PMID:10707367
Abstract

Angiosarcoma of the skin is a rare malignant tumor which is slow-growing but highly aggressive and often recurs following surgery and/or radiation therapy, finally metastasizing to the regional lymph nodes. The ets-1 protooncogene is shown to be transcribed in endothelial cells during angiogenesis in granulation tissue and in malignant cells during tumor invasion. Furthermore, it can regulate the expression of metalloproteinase genes such as collagenase-1 (MMP-1), stromelysin (MMP-3) and urokinase-type plasminogen activator (uPA). In this study we investigated the ets-1 and MMP-1 expression in 7 angiosarcomas of the skin, compared with 7 hemangiomas and 7 granuloma pyogenicums of the skin, which are well known as benign vascular diseases. The ets-1 and MMP-1 mRNAs and their proteins were overexpressed in all angiosarcomas tested, and the localization of MMP-1 expression corresponded to that of ets-1. On the other hand, they were weakly or not at all expressed in hemangiomas and granuloma pyogenicums. These results suggest that the constitutive overexpression of ets-1 might be closely related with the malignant progression of angiosarcoma, possibly through the up-regulation of the transcription of MMP-1.

摘要

皮肤血管肉瘤是一种罕见的恶性肿瘤,生长缓慢但侵袭性强,手术后和/或放疗后常复发,最终转移至区域淋巴结。研究表明,ets-1原癌基因在肉芽组织血管生成过程中的内皮细胞以及肿瘤侵袭过程中的恶性细胞中均有转录。此外,它还可以调节金属蛋白酶基因的表达,如胶原酶-1(MMP-1)、基质溶解素(MMP-3)和尿激酶型纤溶酶原激活剂(uPA)。在本研究中,我们调查了7例皮肤血管肉瘤中ets-1和MMP-1的表达情况,并与7例血管瘤和7例皮肤化脓性肉芽肿进行了比较,后两者均为众所周知的良性血管疾病。在所检测的所有血管肉瘤中,ets-1和MMP-1的mRNA及其蛋白均过度表达,且MMP-1表达的定位与ets-1一致。另一方面,它们在血管瘤和皮肤化脓性肉芽肿中表达较弱或根本不表达。这些结果表明,ets-1的组成性过表达可能与血管肉瘤的恶性进展密切相关,可能是通过上调MMP-1的转录实现的。

相似文献

1
Overexpression of Ets-1 transcription factor in angiosarcoma of the skin.Ets-1转录因子在皮肤血管肉瘤中的过表达。
Pathol Res Pract. 2000;196(2):103-9. doi: 10.1016/S0344-0338(00)80041-2.
2
c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans.c-ets1原癌基因是一种转录因子,在人类肿瘤血管生成及其他形式的血管生成过程中在内皮细胞中表达。
Am J Pathol. 1992 Jan;140(1):119-27.
3
[Expression and significance about VEGF, KDR, MMP-1, and transcription factor Ets-1 in human cervical carcinoma].[血管内皮生长因子、激酶插入区受体、基质金属蛋白酶-1及转录因子Ets-1在人宫颈癌中的表达及意义]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2003 Aug;25(4):396-400.
4
Expression of the Ets-1 proto-oncogene correlates with malignant potential in human astrocytic tumors.Ets-1原癌基因的表达与人类星形细胞瘤的恶性潜能相关。
Mod Pathol. 1999 Jun;12(6):618-26.
5
The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer.在浸润前乳腺癌的基质中,Ets-1转录因子与基质金属蛋白酶1(MMP 1)和基质金属蛋白酶9(MMP 9)一起上调。
J Pathol. 2001 May;194(1):43-50. doi: 10.1002/path.844.
6
Stromal expression of invasion-promoting, matrix-degrading proteases MMP-1 and -9 and the Ets 1 transcription factor in HNPCC carcinomas and sporadic colorectal cancers.HNPCC癌和散发性结直肠癌中促进侵袭、降解基质的蛋白酶MMP - 1和 - 9以及Ets 1转录因子的基质表达。
Int J Cancer. 2003 Nov 1;107(2):183-8. doi: 10.1002/ijc.11336.
7
Ets-1 upregulates matrix metalloproteinase-1 expression through extracellular matrix adhesion in vascular endothelial cells.Ets-1通过血管内皮细胞中的细胞外基质黏附上调基质金属蛋白酶-1的表达。
Biochem Biophys Res Commun. 2002 Feb 15;291(1):130-8. doi: 10.1006/bbrc.2002.6418.
8
Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential.卵巢癌细胞系中各种基质蛋白酶和Ets家族转录因子的表达:与侵袭潜能的相关性
Gynecol Oncol. 2000 Nov;79(2):256-63. doi: 10.1006/gyno.2000.5944.
9
Expression of the ets-1 proto-oncogene in human pancreatic carcinoma.ets-1原癌基因在人胰腺癌中的表达。
Mod Pathol. 1998 Feb;11(2):209-15.
10
Ets-1 transcription factor-mediated urokinase-type plasminogen activator expression and invasion in glioma cells stimulated by serum and basic fibroblast growth factors.Ets-1转录因子介导血清和碱性成纤维细胞生长因子刺激的胶质瘤细胞中尿激酶型纤溶酶原激活剂的表达及侵袭
Lab Invest. 1999 Apr;79(4):407-16.

引用本文的文献

1
ETS1 Protein Expression May Be Altered by the Complementarity of ETS1 mRNA Sequences with miR-203a-3p and miR-204-3p in Papillary Thyroid Carcinoma.在乳头状甲状腺癌中,ETS1 mRNA序列与miR-203a-3p和miR-204-3p的互补性可能会改变ETS1蛋白的表达。
Int J Mol Sci. 2025 Jan 31;26(3):1253. doi: 10.3390/ijms26031253.
2
Hemangiosarcoma in dogs as a potential non-rodent animal model for drug discovery research of angiosarcoma in humans.犬血管肉瘤作为人类血管肉瘤药物发现研究的潜在非啮齿类动物模型。
Front Oncol. 2023 Dec 7;13:1250766. doi: 10.3389/fonc.2023.1250766. eCollection 2023.
3
Primary Breast Angiosarcoma: Comparative Transcriptome Analysis.
原发性乳腺血管肉瘤:比较转录组分析。
Int J Mol Sci. 2022 Dec 16;23(24):16032. doi: 10.3390/ijms232416032.
4
Inhibiting cell migration and cell invasion by silencing the transcription factor ETS-1 in human bladder cancer.通过沉默人膀胱癌中转录因子ETS-1来抑制细胞迁移和细胞侵袭。
Oncotarget. 2016 May 3;7(18):25125-34. doi: 10.18632/oncotarget.7192.
5
Well-differentiated angiosarcoma of spleen: a teaching case mimicking hemagioma and cytogenetic analysis with array comparative genomic hybridization.脾脏高分化血管肉瘤:一例类似血管瘤的教学病例及应用阵列比较基因组杂交技术的细胞遗传学分析
World J Surg Oncol. 2015 Oct 13;13:300. doi: 10.1186/s12957-015-0716-1.
6
MiR-324-5p Suppresses Hepatocellular Carcinoma Cell Invasion by Counteracting ECM Degradation through Post-Transcriptionally Downregulating ETS1 and SP1.微小RNA-324-5p通过转录后下调ETS1和SP1来对抗细胞外基质降解,从而抑制肝癌细胞侵袭。
PLoS One. 2015 Jul 15;10(7):e0133074. doi: 10.1371/journal.pone.0133074. eCollection 2015.
7
Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trial.基线循环 VEGF-A 水平较低与接受索拉非尼治疗的血管肉瘤患者的预后较好相关:一项来自 II 期试验的辅助研究。
Target Oncol. 2014 Sep;9(3):273-7. doi: 10.1007/s11523-013-0299-0. Epub 2013 Nov 12.
8
Molecular mechanisms of ETS transcription factor-mediated tumorigenesis.ETS 转录因子介导的肿瘤发生的分子机制。
Crit Rev Biochem Mol Biol. 2013 Nov-Dec;48(6):522-43. doi: 10.3109/10409238.2013.838202. Epub 2013 Sep 25.
9
Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO).索拉非尼治疗晚期血管肉瘤患者:来自法国肉瘤集团(GSF/GETO)的 II 期试验。
Oncologist. 2012;17(2):260-6. doi: 10.1634/theoncologist.2011-0237. Epub 2012 Jan 27.
10
ETS-1 and ETS-2 are upregulated in a transgenic mouse model of pigmented ocular neoplasm.在色素性眼肿瘤转基因小鼠模型中,ETS-1和ETS-2表达上调。
Mol Vis. 2008;14:1912-28. Epub 2008 Oct 29.